USPTO serial 87780584
NEW A INNOVATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- NELMAN, JESSE M
- Law office
- TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with NEW A INNOVATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
HONG KONG, HK
KOWLOON BAY, KOWLOON, HK
Hong Kong Cytogenetics and Medical Genetics Centre Limited
Hong Kong, HK
Other trademarks owned by Hong Kong Cytogenetics and Medical Genetics Centre Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy T. Wang
TIMOTHY T. WANG NI, WANG & MASSAND, PLLC8140 WALNUT HILL LANE, SUITE 500DALLAS, TX 75231UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | A full line of pharmaceutical and veterinary preparations, namely, prescription and over-the counter medicines for the prevention and treatment of gastrointestinal and hepatobiliary system disease, cardiovascular and hematopoietic system diseases, respiratory system diseases, central nervous system diseases, musculo-skeletal system diseases, hormones related diseases, oncology diseases, genito-urinary system diseases, endocrine and metabolic system diseases, eye diseases, ear and mouth or throat diseases, skin diseases, allergy and immune system diseases and for the use as contraceptive agents, systemic anti-infectives, local and general anesthetics, antidotes; Detoxifying agents and drugs, namely, pharmaceutical agents and biological preparations used to treat substance dependence; Intravenous fluids and other sterile solutions used for rehydration, nutrition and the delivery of pharmaceutical preparations; Vitamins and Mineral supplements; Nutritional supplements for human and animal use; sanitary preparations for medical purposes; Whole blood, blood plasma, blood serum, red blood cells, and hemoglobin solution for medical and veterinary use for the treatment and prevention of acute mountain sickness; medicinal herbs and medicinal herbs in tablet form for medical and veterinary use for the treatment and prevention of acute mountain sickness; Dietetic foods adapted for medical and veterinary use for the treatment and prevention of acute mountain sickness; food for babies; dietary supplements for human consumption and animals; medical plasters; material for stopping teeth; dental wax; disinfectants for hygienic purposes, medical instruments and sanitary purposes; preparations for destroying vermin; fungicides and herbicides | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NEW B INNOVATION LIMITED
- Other trademarks owned by NEW BETA INNOVATION LIMITED
- Other trademarks owned by Hong Kong Cytogenetics and Medical Genetics Centre Limited
- Other trademarks in Class 005
- Similar marks named NEW A INNOVATION
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 18, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 18, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 17, 2019 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 6, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 6, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 30, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 12, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 20, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 20, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 20, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 15, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 15, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 15, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 15, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2018 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 5, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 20, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 13, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 11, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 5, 2018 | NWAP | NEW APPLICATION ENTERED | — |